gilteritinib tablets

On November 28, 2018, the Food and Drug Administration approved gilteritinib tablets for oral use for treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.

Are you looking for or in search of FDA approved “Gilteritinib tablets in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Breast Cancer. Need Access of Gilteritinib tablets, get in touch with our healthcare professional.

gilteritinib tablets price in Latin America, Russia, UK and USA.
gilteritinib tablets

Gilteritinib is used to treat acute myeloid leukemia with an FMS-like tyrosine kinase 3 (FLT3) mutation that has come back or has not improved after previous treatments.Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply.

    gilteritinib tablets

    Contact No.

    Call us
    +91 11 4350 7259

    Emergency Contact
    +91 93139 48015


    Visit us anytime
    F-90/1 , Okhla Industrial Area,
    Phase -1 , New Delhi. India

    Send us an email